| Literature DB >> 23485339 |
Abstract
Recent advances in nanotechnology and material science have re-ignited interest in drug delivery research. Arguably, however, hardly any of the systems developed and strategies proposed are really relevant for shaping the future (clinical) face of the nanomedicine field. Consequently, as outlined in this commentary, instead of making ever more carrier materials, and making nanomedicine both science-fiction and fiction-science, we should try to come up with rational and realistic concepts to make nanomedicines work, in particular in patients.Entities:
Keywords: Cancer; Drug delivery; Drug targeting; EPR; Nanomedicine
Mesh:
Year: 2013 PMID: 23485339 PMCID: PMC3745778 DOI: 10.1016/j.ijpharm.2013.02.046
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875